• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大的口服避孕药使用情况。

Oral contraceptive use in Canada.

作者信息

Rotermann Michelle

机构信息

Health Analysis and Modelling Division, Statistics Canada, Ottawa, Ontario, Canada.

出版信息

Health Rep. 2025 Jun 18;36(6):15-26. doi: 10.25318/82-003-x202500600002-eng.

DOI:10.25318/82-003-x202500600002-eng
PMID:40532082
Abstract

BACKGROUND

Oral contraceptives (OCs) have been legally available in Canada since 1969. OCs remain the most common method of reversible contraception in Canada and are among the most commonly used medications by reproductive-aged women in Canada. The use of OCs offers protection against unplanned pregnancy, in addition to other non-contraceptive benefits. Detailed data about current and lifetime OC use in Canada are rarely available.

METHODS

Data from four cycles (from the 2007-to-2009 cycle to the 2018-to-2019 cycle) of Statistics Canada's Canadian Health Measures Survey were combined to estimate current OC use (past 30 days) by sociodemographic characteristics and other factors and formulations by estrogen dose and progestin type. Logistic regression was used to examine the association between current OC use and sociodemographic characteristics and other factors. Combined data from 2016-to-2017 and 2018-to-2019 were used to estimate lifetime OC use and use duration.

RESULTS

According to combined data from the 2007-to-2009 period to the 2018-to-2019 period, an average of 15.9% of non-pregnant women aged 15 to 49 had used OCs in the previous 30 days. Most (98.6%) used OCs containing estrogen and progestin, and 48.7% of them took lower-dose formulations with 10 to 25 micrograms of ethinylestradiol. Younger women aged 15 to 39 were more likely to have used OCs in the previous 30 days than those aged 40 to 49. Additionally, the adjusted odds of being an OC user were higher for women who had not had children, were non-racialized and non-Indigenous, and were currently sexually active. Another 53.9% of women aged 15 to 49 reported former use. A majority of both current (67.5%) and former (52.8%) OC users reported having used them for at least four years.

INTERPRETATION

Substantial proportions of reproductive-aged women in Canada are current or former OC users.

摘要

背景

自1969年起,口服避孕药(OCs)在加拿大可合法获取。OCs仍是加拿大最常用的可逆性避孕方法,也是加拿大育龄女性最常用的药物之一。使用OCs除了能防止意外怀孕外,还有其他非避孕益处。目前加拿大关于OCs当前使用情况和终生使用情况的详细数据很少。

方法

将加拿大统计局加拿大健康措施调查四个周期(从2007 - 2009周期到2018 - 2019周期)的数据合并,以按社会人口学特征及其他因素估算当前OCs使用情况(过去30天内),并按雌激素剂量和孕激素类型估算配方。采用逻辑回归分析当前OCs使用情况与社会人口学特征及其他因素之间的关联。使用2016 - 2017年和2018 - 2019年的合并数据估算OCs终生使用情况和使用时长。

结果

根据2007 - 2009年至2018 - 2019年的合并数据,在过去30天内,平均15.9%的15至49岁非孕妇使用过OCs。大多数(98.6%)使用含雌激素和孕激素的OCs,其中48.7%服用含10至25微克乙炔雌二醇的低剂量配方。15至39岁的年轻女性在过去30天内使用OCs的可能性高于40至49岁的女性。此外,未育、非种族化且非原住民、当前有性行为的女性使用OCs的校正比值更高。另有53.9%的15至49岁女性报告曾使用过OCs。当前(67.5%)和曾经(52.8%)使用OCs的女性中,大多数报告使用时间至少为四年。

解读

加拿大相当比例的育龄女性是当前或曾经的OCs使用者。

相似文献

1
Oral contraceptive use in Canada.加拿大的口服避孕药使用情况。
Health Rep. 2025 Jun 18;36(6):15-26. doi: 10.25318/82-003-x202500600002-eng.
2
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
3
Prevalence and correlates of contraceptive use among adolescent mothers: Results from a cross-sectional survey in Ouagadougou, Burkina Faso, and Blantyre, Malawi.青少年母亲中避孕措施的使用情况及其相关因素:布基纳法索瓦加杜古和马拉维布兰太尔横断面调查结果
PLoS One. 2025 Jun 18;20(6):e0319136. doi: 10.1371/journal.pone.0319136. eCollection 2025.
4
Sleep, Health Care-Seeking Behaviors, and Perceptions Associated With the Use of Sleep Wearables in Canada: Results From a Nationally Representative Survey.加拿大与睡眠可穿戴设备使用相关的睡眠、医疗保健寻求行为及认知:一项全国代表性调查的结果
J Med Internet Res. 2025 Jun 17;27:e68816. doi: 10.2196/68816.
5
Oral contraceptive use among women aged 15 to 49: Results from the Canadian Health Measures Survey.15至49岁女性的口服避孕药使用情况:加拿大健康措施调查结果
Health Rep. 2015 Oct;26(10):21-8.
6
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
7
Absorbent products for moderate-heavy urinary and/or faecal incontinence in women and men.适用于女性和男性中重度尿失禁和/或大便失禁的吸收性产品。
Cochrane Database Syst Rev. 2008 Oct 8(4):CD007408. doi: 10.1002/14651858.CD007408.
8
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
9
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
10
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.不明病因复发性流产女性预防流产的孕激素治疗
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003511. doi: 10.1002/14651858.CD003511.pub6.